Clinical Trial Update: Performance Comparison of Masimo O3 Regional Oximetry Sensors in Neonates [NA]

View source ↗

Summary

A terminated clinical trial comparing Masimo O3 regional oximetry sensors in neonates; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Regional Oxygen Saturation Monitoring

Drugs mentioned

• Masimo O3 regional oximetry sensors (Masimo O3 regional oximetry sensors)

Snippet

Sponsor: Masimo Corporation | Conditions: Regional Saturation of Oxygen (rSO2) | NA | Status: TERMINATED | Results posted: 2021-06-07